These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38417040)

  • 1. Insights on Structure-Passive Permeability Relationship in Pyrrole and Furan-Containing Macrocycles.
    Ly HM; Desgagné M; Nguyen DT; Comeau C; Froehlich U; Marsault É; Boudreault PL
    J Med Chem; 2024 Mar; 67(5):3711-3726. PubMed ID: 38417040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Permeability Relationship of Semipeptidic Macrocycles-Understanding and Optimizing Passive Permeability and Efflux Ratio.
    Le Roux A; Blaise É; Boudreault PL; Comeau C; Doucet A; Giarrusso M; Collin MP; Neubauer T; Kölling F; Göller AH; Seep L; Tshitenge DT; Wittwer M; Kullmann M; Hillisch A; Mittendorf J; Marsault E
    J Med Chem; 2020 Jul; 63(13):6774-6783. PubMed ID: 32453569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Rule-of-five: Permeability Assessment of Semipeptidic Macrocycles.
    L'Exact M; Comeau C; Bourhis A; Boisvert O; Fröhlich U; Létourneau D; Marsault É; Lavigne P; Grandbois M; Boudreault PL
    Biochim Biophys Acta Biomembr; 2023 Oct; 1865(7):184196. PubMed ID: 37400050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the Passive Permeability of Semipeptidic Macrocycles: N- and C-Methylations Fine-Tune Conformation and Properties.
    Comeau C; Ries B; Stadelmann T; Tremblay J; Poulet S; Fröhlich U; Côté J; Boudreault PL; Derbali RM; Sarret P; Grandbois M; Leclair G; Riniker S; Marsault É
    J Med Chem; 2021 May; 64(9):5365-5383. PubMed ID: 33750117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Property-Driven Development of Passively Permeable Macrocyclic Scaffolds Using Heterocycles.
    Saunders GJ; Yudin AK
    Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202206866. PubMed ID: 35687524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
    Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
    Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
    Ottaviani G; Martel S; Carrupt PA
    J Med Chem; 2006 Jun; 49(13):3948-54. PubMed ID: 16789751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell permeability beyond the rule of 5.
    Matsson P; Doak BC; Over B; Kihlberg J
    Adv Drug Deliv Rev; 2016 Jun; 101():42-61. PubMed ID: 27067608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.
    Tsinman O; Tsinman K; Sun N; Avdeef A
    Pharm Res; 2011 Feb; 28(2):337-63. PubMed ID: 20945153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors.
    Li C; Nair L; Liu T; Li F; Pichardo J; Agrawal S; Chase R; Tong X; Uss AS; Bogen S; Njoroge FG; Morrison RA; Cheng KC
    Biochem Pharmacol; 2008 Mar; 75(5):1186-97. PubMed ID: 18164692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection.
    Liu H; Sabus C; Carter GT; Du C; Avdeef A; Tischler M
    Pharm Res; 2003 Nov; 20(11):1820-6. PubMed ID: 14661927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting both passive intestinal absorption and the dissociation constant toward albumin using the PAMPA technique.
    Bujard A; Sol M; Carrupt PA; Martel S
    Eur J Pharm Sci; 2014 Oct; 63():36-44. PubMed ID: 25008117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the Passive Intestinal Absorption of Medicinal Plant Extract Constituents with the Parallel Artificial Membrane Permeability Assay (PAMPA).
    Petit C; Bujard A; Skalicka-Woźniak K; Cretton S; Houriet J; Christen P; Carrupt PA; Wolfender JL
    Planta Med; 2016 Mar; 82(5):424-31. PubMed ID: 26872320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, solubility, and permeability relationships in a diverse middle molecule library.
    Miyachi H; Kanamitsu K; Ishii M; Watanabe E; Katsuyama A; Otsuguro S; Yakushiji F; Watanabe M; Matsui K; Sato Y; Shuto S; Tadokoro T; Kita S; Matsumaru T; Matsuda A; Hirose T; Iwatsuki M; Shigeta Y; Nagano T; Kojima H; Ichikawa S; Sunazuka T; Maenaka K
    Bioorg Med Chem Lett; 2021 Apr; 37():127847. PubMed ID: 33571648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Phenothiazine Embedded Heteroporphyrins.
    Tripathi N; Sinha A; Ravikanth M
    Chem Asian J; 2024 Jan; 19(2):e202300952. PubMed ID: 38055208
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Assmus F; Ross A; Fischer H; Seelig J; Seelig A
    Mol Pharm; 2017 Jan; 14(1):284-295. PubMed ID: 27977215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs.
    Danelius E; Poongavanam V; Peintner S; Wieske LHE; Erdélyi M; Kihlberg J
    Chemistry; 2020 Apr; 26(23):5231-5244. PubMed ID: 32027758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.